RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy.
about
Evaluation of protein biomarkers of prostate cancer aggressivenessThe hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cellsThe biology of CD44 and HCELL in hematopoiesis: the 'step 2-bypass pathway' and other emerging perspectivesInteractions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and CancerThe roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progressionElevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumorsAbnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms.CD44-mediated adhesion to hyaluronic acid contributes to mechanosensing and invasive motilityTRBP ensures efficient Dicer processing of precursor microRNA in RNA-crowded environments.CD44 deficiency improves healing tendon mechanics and increases matrix and cytokine expression in a mouse patellar tendon injury model.CD44 expression is developmentally regulated in the mouse lens and increases in the lens epithelium after injury.Nanoparticle delivery and combination therapy of gambogic acid and all-trans retinoic acidLymphatics in idiopathic pulmonary fibrosis: new insights into an old disease.High and low molecular weight hyaluronic acid differentially regulate human fibrocyte differentiation.Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosisHyaluronan as an immune regulator in human diseases.Silencing of CD44 gene expression in human 143-B osteosarcoma cells promotes metastasis of intratibial tumors in SCID micec-Met recruits ICAM-1 as a coreceptor to compensate for the loss of CD44 in Cd44 null mice.Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology.Hyaluronan fragments promote inflammation by down-regulating the anti-inflammatory A2a receptor.CD44: molecular interactions, signaling and functions in the nervous systemCan CD44 Be a Mediator of Cell Destruction? The Challenge of Type 1 Diabetes.Hyaluronic acid receptor CD44 deficiency is associated with decreased Cryptococcus neoformans brain infectionRhamm-/- fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repairProstacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis.Upregulation of hyaluronan-mediated motility receptor in hepatocellular carcinoma predicts poor survival.Hyaluronidases and hyaluronan synthases expression is inversely correlated with malignancy in lung/bronchial pre-neoplastic and neoplastic lesions, affecting prognosis.Profiles of microRNA networks in intestinal epithelial cells in a mouse model of colitis.Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronanInteraction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids.Hyaluronan oligosaccharides perturb lymphocyte slow rolling on brain vascular endothelial cells: implications for inflammatory demyelinating disease.CD44 involvement in autoimmune inflammations: the lesson to be learned from CD44-targeting by antibody or from knockout mice.Role of the extracellular matrix in variations of invasive pathways in lung cancers.Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGFβ receptor interaction via CD44-PKCδ.Epidermal-specific deletion of CD44 reveals a function in keratinocytes in response to mechanical stress.Targeting CD44 in mast cell regulation.Evaluation of the effects of hyaluronic acid-carboxymethyl cellulose barrier on ovarian tumor progression.Deregulation of hyaluronan synthesis, degradation and binding promotes breast cancer.Hyaluronan and RHAMM in wound repair and the "cancerization" of stromal tissues.Editorial: Interaction Between Hyaluronic Acid and Its Receptors (CD44, RHAMM) Regulates the Activity of Inflammation and Cancer.
P2860
Q21261257-1C44F690-7EFE-4636-B4F7-5F43F2B50780Q24595836-CB614025-3BBB-4501-B11D-4E3E72CB22FFQ24628178-46253145-0F3B-48B9-8E38-0E0885FFF386Q27021261-B3C2D374-8F8A-4362-A589-722519EBEEB3Q27025313-BE28EAB8-FD31-47B4-951D-652821EB6A89Q28236788-905710BC-6092-4487-8CF4-45C52D40AA5DQ30486123-0705AE19-00C5-473C-A697-A375E0A57BD6Q30594175-F2B60432-E1EB-4234-9839-5C431878EDDAQ30831870-3ACB710B-6C64-4394-8263-6DB4CACB10B7Q33608231-25483BA6-9AEE-4875-8EC8-931D48C95A32Q33721902-2BC24B68-7D0C-4542-AD6A-F4181DB2D4D2Q33904975-F4B29737-34BC-412E-AC1D-2D923D32462CQ33905052-6F0DC039-04FE-45FC-9ACB-E1CB77CC93DFQ34055945-86F5A4FB-53D0-499C-9365-CB46A29CAD1FQ34560457-CC067C0E-9F03-404C-AA4F-B62BE1095C31Q34636380-150EFCFD-59B8-4026-9163-332B71D38B35Q34658335-978FE263-C30D-41C4-9206-5BFFF2EA42BCQ35133627-2751D136-FCFC-4E25-9686-A5A890B34D2DQ35159732-FDB1FAFC-73DD-483D-BCC9-50C337CBFC56Q35528026-66FB2734-3CEA-435E-ABA6-DDC59B5B65E1Q35580052-6CEF8783-7665-4E9B-8B57-95209ED0A86FQ35856862-875440A1-48BE-4C01-8D87-E5CD751AF491Q35939738-75028EDF-5FFB-45D6-A06C-6FEAB1CC8E17Q36119479-23BF2954-606C-4C2B-BC24-EBA9D6CC27B1Q36228311-B51DB726-7464-45FC-91C9-E7757AE5E183Q36334849-B62D3D0D-AC19-4A41-A89E-514F9B77264EQ36351747-6665B7BC-CACA-4C50-8A18-CC15B41C74A9Q36357175-EBF9D668-4F0C-4B0D-9D55-045C733476ECQ36499699-0F9D741E-0BE7-43DF-BACC-2A3D38538C7CQ36537945-28223251-4BC9-42A7-821B-E311F5B0F3F1Q36807714-CCCF2A6B-603B-46BF-ABCD-438DFFABF695Q36958322-4C2BE78D-1E1B-47A5-9AF2-7489491FC464Q37371321-1C025803-20CC-42F5-9F93-9941E0DB4057Q37461694-A9D010DF-8600-41AC-BF75-DB2D42731AA3Q37603281-F8C554BC-E688-4A75-B1D9-635A15B01DCCQ37650176-4AD1D7FF-6617-4D97-B1D0-F4812829D1E0Q37718751-C0FB6ED1-C8C6-46B4-A4C0-5EBA4D534112Q38149106-A719DD97-F5B0-45D4-A48B-15339EF52C85Q38243335-5B4D12D5-8973-4F3C-83C2-C55BD29418C9Q38281132-88F2764C-D894-45A9-B05E-67C30236995D
P2860
RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy.
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
RHAMM, a receptor for hyaluron ...... interpretation of redundancy.
@ast
RHAMM, a receptor for hyaluron ...... interpretation of redundancy.
@en
RHAMM, a receptor for hyaluron ...... interpretation of redundancy.
@nl
type
label
RHAMM, a receptor for hyaluron ...... interpretation of redundancy.
@ast
RHAMM, a receptor for hyaluron ...... interpretation of redundancy.
@en
RHAMM, a receptor for hyaluron ...... interpretation of redundancy.
@nl
prefLabel
RHAMM, a receptor for hyaluron ...... interpretation of redundancy.
@ast
RHAMM, a receptor for hyaluron ...... interpretation of redundancy.
@en
RHAMM, a receptor for hyaluron ...... interpretation of redundancy.
@nl
P2093
P2860
P356
P1476
RHAMM, a receptor for hyaluron ...... interpretation of redundancy.
@en
P2093
Birgit A Neudecker
David Naor
Erez Gonen
Eva A Turley
Fu-Sheng Wang
Jing-Feng Huang
Nathalie Assayag
Reuven Reich
Richard O Williams
Shlomo Nedvetzki
P2860
P304
18081-18086
P356
10.1073/PNAS.0407378102
P407
P577
2004-12-13T00:00:00Z